Medlogics nets CE Mark for new bare metal stent

Medlogics Device’s Cobra Coronary Stent System has received the CE Mark based on the chronic preclinical implants performed at Saint Joseph’s Translational Research Institute (SJTRI) in Atlanta, which demonstrated the safety and efficacy of the stent.

The Cobra Coronary Stent System combines a unique design and a cobalt super alloy for thinner struts without sacrificing radial strength, according to the Santa Rosa, Calif.-based company.

In addition to working on its BMS program, SJTRI is conducting further research with Medlogics on their drug-eluting stent (DES) programs.

Medlogics said its DES has a silica-based coating that is gradually absorbed by the body after delivery of the drug, potentially reducing the risk of clotting and the burden of pharmacotherapy.

Medlogics recently reported that it has licensed CV Therapeutics’ proprietary biopolymer stent coating technology for the development of a new stent based on the Cobra platform.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.